We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
CareDx
CDNA
$2.42B
| $1.05M | ﹤0.01% |
87,180
-2,124
| -2% | -$17.4K |
|
2202
Merchants Bancorp
MBIN
$2.49B
| $1.04M | ﹤0.01% |
24,504
-28
| -0.1% | -$920 |
|
|
IMOS
2203
ChipMOS TECHNOLOGIES
IMOS
$1.83B
| $1.04M | ﹤0.01% |
38,344
+246
| +0.6% | +$6.18K |
|
2204
SandRidge Energy
SD
$503M
| $1.04M | ﹤0.01% |
76,069
-3,756
| -5% | -$55.5K |
|
|
RNAM
2205
DELISTED
Avidity Biosciences
RNAM
| $1.04M | ﹤0.01% |
114,767
+4,330
| +4% | +$28.9K |
|
|
CNSL
2206
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $1.04M | ﹤0.01% |
238,505
-4,101
| -2% | -$17K |
|
2207
Life Time Group Holdings
LTH
$9.79B
| $1.04M | ﹤0.01% |
68,793
+21
| +0% | +$301 |
|
2208
Grid Dynamics Holdings
GDYN
$615M
| $1.04M | ﹤0.01% |
77,659
+716
| +0.9% | +$8.73K |
|
|
CBL
2209
CBL Properties
CBL
$1.75B
| $1.03M | ﹤0.01% |
42,323
+328
| +0.8% | +$7.32K |
|
|
KE
2210
Kimball Electronics
KE
$628M
| $1.03M | ﹤0.01% |
38,075
-3,479
| -8% | -$89.7K |
|
|
BASE
2211
DELISTED
Couchbase
BASE
| $1.02M | ﹤0.01% |
45,377
+1,312
| +3% | +$24K |
|
2212
Aehr Test Systems
AEHR
$3.36B
| $1.02M | ﹤0.01% |
38,471
+504
| +1% | +$14.7K |
|
|
MTTR
2213
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $1.02M | ﹤0.01% |
379,242
+1,810
| +0.5% | +$4.35K |
|
2214
Alignment Healthcare
ALHC
$2.98B
| $1.02M | ﹤0.01% |
118,480
-1,305
| -1% | -$9.54K |
|
2215
Vita Coco
COCO
$3.6B
| $1.02M | ﹤0.01% |
39,728
-819
| -2% | -$22.2K |
|
|
PTVE
2216
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $1.02M | ﹤0.01% |
74,214
+3,516
| +5% | +$37K |
|
2217
AB InBev
BUD
$165B
| $1.02M | ﹤0.01% |
15,714
+229
| +1% | +$13.5K |
|
2218
Amerant Bancorp
AMTB
$1.13B
| $1.01M | ﹤0.01% |
41,271
-130
| -0.3% | -$2.69K |
|
2219
Dyne Therapeutics
DYN
$4.9B
| $1.01M | ﹤0.01% |
76,238
+5,667
| +8% | +$55.4K |
|
2220
Univest Financial
UVSP
$1.18B
| $1.01M | ﹤0.01% |
45,994
-2,153
| -4% | -$40.3K |
|
|
SWI
2221
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.01M | ﹤0.01% |
81,084
-380
| -0.5% | -$4.08K |
|
2222
RELX
RELX
$62B
| $1.01M | ﹤0.01% |
25,483
-413
| -2% | -$15.2K |
|
2223
Conduent
CNDT
$264M
| $1.01M | ﹤0.01% |
276,479
+1,307
| +0.5% | +$4.13K |
|
2224
TFS Financial
TFSL
$4.93B
| $1.01M | ﹤0.01% |
68,453
-3,113
| -4% | -$40.2K |
|
2225
Amylyx Pharmaceuticals
AMLX
$2.54B
| $1.01M | ﹤0.01% |
68,283
-677
| -1% | -$10.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.